Aarti Pharmalabs Ltd.

The company's total revenue for the quarter ended March 2023 saw a slight change in the total revenue, having registered a total revenue of Rs. 3742.70 millions.Net profit declined -10.87% to Rs. 400.00 millions from Rs. 448.80 millions.OP of the company witnessed a marginal growth to 768.00 millions from 707.20 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202303	202203	% Var	202303	202203	% Var	202303	202203	% Var
Sales	3742.70	3647.00	2.62	15112.50	9410.20	60.60	15112.50	9410.20	60.60
Other Income	0.00	25.10	-100.00	12.80	25.10	-49.00	12.80	25.10	-49.00
PBIDT	768.00	707.20	8.60	3096.20	1822.90	69.85	3096.20	1822.90	69.85
Interest	58.00	44.00	31.82	204.90	113.40	80.69	204.90	113.40	80.69
PBDT	710.00	663.20	7.06	2891.30	1709.50	69.13	2891.30	1709.50	69.13
Depreciation	142.50	124.40	14.55	557.70	372.30	49.80	557.70	372.30	49.80
PBT	567.50	538.80	5.33	2333.60	1337.20	74.51	2333.60	1337.20	74.51
TAX	167.50	90.00	86.11	616.30	270.00	128.26	616.30	270.00	128.26
Deferred Tax	27.50	15.00	83.33	95.00	45.00	111.11	95.00	45.00	111.11
PAT	400.00	448.80	-10.87	1717.30	1067.20	60.92	1717.30	1067.20	60.92
Equity	453.10	455.60	-0.55	453.10	455.60	-0.55	453.10	455.60	-0.55
PBIDTM(%)	20.52	19.39	5.82	20.49	19.37	5.76	20.49	19.37	5.76